{"article":{"annotation":{"article_id":"india-nppa-543-cancer-medicine-brands-revised-prices-2026","available_at":"2026-10-28T15:58:00.227233Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"f5a725f394998e89147dc0f8c25751d51e59c95c8092aed77bb09776598c43d2","input_sha256":"13f7e3a5bfc828f5f9d82bda524fa30949989db61a72023942652ae94306be58","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"IN","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698"]}],"geometry":null,"id":"iso3166-1:IN","kind":"country-or-area","labels":{"ar":"الهند","en":"India","es":"India","fr":"Inde"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000447","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: cancer","source_urls":["https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698"]}],"method":"controlled-rules-v1","rule_id":"cancer","status":"candidate"},{"concept_id":"medtop:20000252","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: retail prices","source_urls":["https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698"]}],"method":"controlled-rules-v1","rule_id":"retail","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=es","category":"health","content":{"key_points":[],"paragraphs":["La Autoridad Nacional de Precios Farmacéuticos de India publicó el 28 de octubre los precios máximos de venta al público revisados para 543 marcas de medicamentos contra el cáncer. Los nuevos precios entrarán en vigor el 9 de noviembre de 2026, según el anuncio del Departamento de Productos Farmacéuticos.","La lista refleja las declaraciones de fabricantes recibidas hasta el 27 de octubre y se actualizará a medida que lleguen nuevos precios revisados. Sigue a la decisión de la autoridad del 17 de octubre de racionalizar los márgenes comerciales de 137 medicamentos contra el cáncer no incluidos en la lista regulatoria de precios. Las cantidades de marcas y medicamentos miden cosas distintas y no deben sumarse.","Por ejemplo, la tabla publicada indica que Anarzole, comprimidos de 1 mg en un envase de diez unidades, tiene un precio máximo revisado de 73 rupias, frente a 695,76 rupias anteriormente. Las cifras corresponden a esa marca, concentración y envase. No establecen el precio de todos los productos de anastrozol ni si los nuevos precios se cobran antes de la fecha de entrada en vigor."],"sections":[]},"corrections":[],"country":"IN","data":{"blocks":[{"description":{"ar":"نشر الإعلان الرسمي في 28 أكتوبر 2026.","de":"Veröffentlichung der offiziellen Mitteilung am 28. Oktober 2026.","en":"Publication of the official announcement on 28 October 2026.","es":"Publicación del anuncio oficial el 28 de octubre de 2026.","fr":"Publication de l’annonce officielle le 28 octobre 2026.","pt":"Publicação do anúncio oficial em 28 de outubro de 2026.","tr":"Resmî duyurunun 28 Ekim 2026’da yayımlanması."},"id":"source-announcement","items":[{"date":"2026-10-28","description":{"ar":"أصدرت الهيئة الوطنية لتسعير الأدوية في الهند الأسعار القصوى المعدلة للبيع بالتجزئة لـ543 علامة تجارية من أدوية السرطان في 28 أكتوبر. وتدخل الأسعار الجديدة حيز التنفيذ في 9 نوفمبر 2026، وفق إعلان إدارة الأدوية.","de":"Laut Mitteilung des Arzneimittelministeriums treten die neuen Preise am 9. November 2026 in Kraft. Die Nationale Pharmazeutische Preisbehörde Indiens veröffentlichte am 28. Oktober überarbeitete maximale Einzelhandelspreise für 543 Marken von Krebsarzneimitteln.","en":"India’s National Pharmaceutical Pricing Authority released revised maximum retail prices for 543 anti-cancer medicine brands on 28 October. The new prices take effect on 9 November 2026, according to the Department of Pharmaceuticals announcement.","es":"La Autoridad Nacional de Precios Farmacéuticos de India publicó el 28 de octubre los precios máximos de venta al público revisados para 543 marcas de medicamentos contra el cáncer. Los nuevos precios entrarán en vigor el 9 de noviembre de 2026, según el anuncio del Departamento de Productos Farmacéuticos.","fr":"L’Autorité nationale indienne de tarification pharmaceutique a publié le 28 octobre les prix maximaux de vente au détail révisés pour 543 marques de médicaments anticancéreux. Selon le Département des produits pharmaceutiques, les nouveaux prix entreront en vigueur le 9 novembre 2026.","pt":"A Autoridade Nacional de Preços Farmacêuticos da Índia publicou em 28 de outubro preços máximos de venda a retalho revistos para 543 marcas de medicamentos anticancerígenos. Os novos preços entram em vigor em 9 de novembro de 2026, segundo o anúncio do Departamento de Produtos Farmacêuticos.","tr":"Hindistan Ulusal İlaç Fiyatlandırma Kurumu, 28 Ekim’de 543 kanser ilacı markası için revize edilmiş azami perakende satış fiyatlarını açıkladı. İlaçlar Dairesinin duyurusuna göre yeni fiyatlar 9 Kasım 2026’da yürürlüğe girecek."},"label":{"ar":"الهند تنشر الأسعار القصوى المعدلة لـ543 علامة دواء للسرطان","de":"Indien veröffentlicht neue Höchstpreise für 543 Krebsarzneimittelmarken","en":"India publishes revised maximum prices for 543 cancer medicine brands","es":"India publica precios máximos revisados para 543 marcas de medicamentos contra el cáncer","fr":"L’Inde publie les nouveaux prix plafonds de 543 marques de médicaments anticancéreux","pt":"Índia publica preços máximos revistos para 543 marcas de medicamentos oncológicos","tr":"Hindistan 543 kanser ilacı markasının revize azami fiyatlarını yayımladı"},"status":"occurred"}],"methodology":{"ar":"يسجل التاريخ نشر المصدر الرسمي المذكور، ولا يثبت اكتمال الإجراءات المستقبلية المعلنة.","de":"Das Datum bezeichnet die Veröffentlichung der genannten offiziellen Quelle. Es belegt nicht, dass angekündigte Maßnahmen abgeschlossen wurden.","en":"The date records publication of the cited official source. It does not establish completion of announced future actions.","es":"La fecha corresponde a la publicación de la fuente oficial citada. No confirma que se hayan completado las acciones anunciadas.","fr":"La date correspond à la publication de la source officielle citée. Elle ne confirme pas la réalisation des actions annoncées.","pt":"A data regista a publicação da fonte oficial citada. Não comprova a conclusão das ações anunciadas.","tr":"Tarih, belirtilen resmî kaynağın yayımlandığı günü gösterir; duyurulan gelecek eylemlerin tamamlandığını kanıtlamaz."},"sourceUrls":["https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698"],"title":{"ar":"نشر المصدر الرسمي","de":"Veröffentlichung der offiziellen Quelle","en":"Source publication","es":"Publicación de la fuente oficial","fr":"Publication de la source officielle","pt":"Publicação da fonte oficial","tr":"Resmî kaynağın yayımlanması"},"type":"events","updatedAt":"2026-10-28T15:45:01Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026/data/source-announcement?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026/data/source-announcement?lang=es&format=json"},"id":"source-announcement"}],"data_types":["events"],"editorial_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-8e5df001-692c-56f6-8edf-966d8e4324eb","event_period":"2026-10-28","event_period_basis":"event-or-reference-period","id":"india-nppa-543-cancer-medicine-brands-revised-prices-2026","image":null,"importance":0.6,"language":"es","modified_at":"2026-10-28T15:57:55+00:00","publication_basis":"publication-record","published_at":"2026-10-28T15:57:55+00:00","reading_minutes":2,"region":"world","relations":[],"section_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"india-nppa-543-cancer-medicine-brands-revised-prices-2026","sources":[{"checkedAt":"2026-10-28","name":"Press Information Bureau, Government of India","publishedAt":"2026-10-28","url":"https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2329698"}],"summary":"La Autoridad Nacional de Precios Farmacéuticos de India publicó el 28 de octubre los precios máximos de venta al público revisados para 543 marcas de medicamentos contra el cáncer.","text":"La Autoridad Nacional de Precios Farmacéuticos de India publicó el 28 de octubre los precios máximos de venta al público revisados para 543 marcas de medicamentos contra el cáncer.\n\nLa Autoridad Nacional de Precios Farmacéuticos de India publicó el 28 de octubre los precios máximos de venta al público revisados para 543 marcas de medicamentos contra el cáncer. Los nuevos precios entrarán en vigor el 9 de noviembre de 2026, según el anuncio del Departamento de Productos Farmacéuticos.\n\nLa lista refleja las declaraciones de fabricantes recibidas hasta el 27 de octubre y se actualizará a medida que lleguen nuevos precios revisados. Sigue a la decisión de la autoridad del 17 de octubre de racionalizar los márgenes comerciales de 137 medicamentos contra el cáncer no incluidos en la lista regulatoria de precios. Las cantidades de marcas y medicamentos miden cosas distintas y no deben sumarse.\n\nPor ejemplo, la tabla publicada indica que Anarzole, comprimidos de 1 mg en un envase de diez unidades, tiene un precio máximo revisado de 73 rupias, frente a 695,76 rupias anteriormente. Las cifras corresponden a esa marca, concentración y envase. No establecen el precio de todos los productos de anastrozol ni si los nuevos precios se cobran antes de la fecha de entrada en vigor.","title":"India publica precios máximos revisados para 543 marcas de medicamentos contra el cáncer","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},{"api_url":"https://newsverum.com/api/v1/articles/india-nppa-543-cancer-medicine-brands-revised-prices-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"}],"url":"https://newsverum.com/es/news/india-nppa-543-cancer-medicine-brands-revised-prices-2026"},"version":"1"}
